Search our Roles
Latest News
- AstraZeneca gains priority review from FDA for Imfinzi fixed dose regime
- FDA approval given to Catalent as an additional manufacturing site for gene therapy
- FDA approve Janssen’s depression nasal spray
- European Commision approves subcutaneous version of Remsima for IBD and ankylosing spondylitis
- C-Path obtain FDA’s positive response for drug induced skeletal muscle injury biomarkers